Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort-Reference-Cited by-同舟云学术

Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort

Published:2020-06 Issue:3 Volume:50 Page:492-497
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Barsotti Simone,Dastmalchi Maryam,Notarnicola Antonella,Leclaire Valerie,Dani Lara,Gheorghe Karina,Ekholm Louise,Bottai Matteo,Tjärnlund Anna,Lundberg Ingrid E.

Funder

Swedish Research Council

Swedish Rheumatism Association

King Gustaf V 80-year Foundation

Rheumatism Association

Stockholm County Council

Karolinska Institutet

University of Siena

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference24 articles.

1. Polymyositis and dermatomyositis (first of two parts);Bohan;N Engl J Med,1975

2. Polymyositis and dermatomyositis (second of two parts);Bohan;N Engl J Med,1975

3. New myositis classification criteria-what we have learned since Bohan and Peter;Leclair;Curr Rheumatol Rep,2018

4. 2017 European league against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups;Lundberg;Ann Rheum Dis.,2017

5. 2017 European league against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups;Lundberg;Arthritis Rheumatol,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network;Seminars in Arthritis and Rheumatism;2024-10

2. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27

3. Dermatomyositis: Practical Guidance and Unmet Needs;ImmunoTargets and Therapy;2024-03

4. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study;Frontiers in Immunology;2023-11-27

5. Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy;Frontiers in Immunology;2023-08-10